Navigation Links
BG Medicine Signs Collaborative Research Agreement with the National Heart, Lung and Blood Institute (NHLBI), and Boston University
Date:3/12/2009

event heart attacks and stroke," said NHLBI Director Elizabeth G. Nabel, M.D.

"We are grateful to the thousands of people who have participated in the Framingham Heart Study over the last six decades -- their cooperation will again help scientists make great strides in understanding, preventing, and treating cardiovascular diseases."

Only information from participants who have consented to sharing their specimens and data with commercial researchers will be used, and all shared information will be de-identified to protect participants' privacy.

"The collaborative research planned under this agreement focuses on blood biomarkers of atherosclerotic vascular disease as determined by multiple imaging modalities," said Valentin Fuster, M.D., Ph.D. director of Mount Sinai Heart at the Mt. Sinai Medical Center in New York, NY, and chairman of another cardiovascular biomarker initiative known as the HRP Initiative.

"This will further contribute to our insight in the discrepancies between risk factors and disease -- some people with multiple risk factors are disease-free, while others with a favorable risk factor profile have extensive atherosclerotic vascular disease."

"It is an honor and a privilege to be able to participate in this important research using the Framingham biosamples," said Pieter Muntendam, M.D., Chief Executive Officer of BG Medicine (www.bg-medicine.com). "Use of these advanced research platforms now enable the kind of biomarker research that was impossible just a couple of years ago."

BG Medicine also is playing a lead role in the HRP Initiative (www.HRPInitiative.com). The HRP initiative is conducting a number of studies to discover and validate novel blood or imaging biomarkers of atherosclerosis and risk for atherothrombosis.

'/>"/>

SOURCE BG Medicine
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. GPhA Statement on the Introduction of the Bipartisan Biogenerics Consensus Bill: Promoting Innovation and Access to Life-Saving Medicine Act
2. China Medicine to Participate in 2009 Natural Products Expo West Trade Show
3. Data on WaferGens SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-Conference
4. Data on WaferGens SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference
5. The Biggest Names in the Field of Personalized Medicine to Speak at Arrowhead's Upcoming 2009 Personalized Medicine Conference
6. Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine
7. Adoption of Personalized Medicine May Yield Significant ROI; Time to Achieve Benefit Varies Among U.S. Health Care Stakeholders, According to Deloitte Report
8. Cordex Pharma Presents New Frontiers in Cardiovascular Medicines on January 29
9. Rules-Based Medicine, Inc. Launches Human Kidney Damage Biomarker Panel
10. Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice
11. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Richmond, VA (PRWEB) November 21, 2014 ... businessman who understood the need to surround himself with ... visionary, CEO and entrepreneur, his friends often marveled at ... how he lived his life and -- even with ... cure for the Alzheimer’s disease that would ultimately take ...
(Date:11/22/2014)... On November 17th Chicago start-up Briteseed ... Medical Technologies Summit in San Francisco to take first ... among Silicon Valley investors and technology elites as the ... also positions Briteseed to move on to the ... and compete with other elite innovation finalists for a ...
(Date:11/22/2014)... 2014   , ... Officer zu KLOX    ... Financial Officer bestellt    KLOX ist ... jüngst zugelassenen Behandlungssystems zur Wundheilung zu beginnen    , ... ist sehr erfreut, die folgenden personellen Veränderungen anzukündigen: ...
(Date:11/21/2014)... Offering a complete line of laboratory ... promotion . The Sartorius Entris Balance is the perfect ... and easy-to-maintain balance entry level balance. , The Entris ... to help customer’s bridge the gap between a basic ... very durable. Sartorius is the second biggest balance manufacturer ...
Breaking Biology Technology:Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 3Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 2Insight Product Development Accelerator Member Wins MedTech Innovator Award Competition 3KLOX Technologies meldet Neubesetzung von Führungspositionen 2KLOX Technologies meldet Neubesetzung von Führungspositionen 3KLOX Technologies meldet Neubesetzung von Führungspositionen 4KLOX Technologies meldet Neubesetzung von Führungspositionen 5Pipette.com Announces an Extension on the Sartorius Entris Balance Promotion to the End of 2014 2
... 20 percent of the world,s industrial production is based ... of chemical reactions by factors of billions. Oil, pharmaceuticals, ... Many are hoping to make current ... less pollution. Highly active and selective nanocatalysts, for example, ...
... (Nasdaq: MYL ) announced today that it will ... 3, 2011, at 8:30 a.m. ET, to review the company,s ... 31, 2011. Mylan will release its financial results on May ... to access the call is 800.479.9001 or 719.325.2146 for international ...
... April 20, 2011 In its first full year as a ... annual revenue by 55 percent over 2009 and grew Q4 revenue ... released today. Annual sales reached $5.4 million, up by ... million, up by $800,000 from the same quarter of 2009. ...
Cached Biology Technology:UCLA researchers now 1 step closer to controlled engineering of nanocatalysts 2Divine Skin Posts Record Sales for 2010: Up 55% Over 2009 2Divine Skin Posts Record Sales for 2010: Up 55% Over 2009 3
(Date:11/12/2014)... GARDENS, Fla. , Nov. 12, 2014 ... announced today that its U.are.U ® fingerprint readers ... bakery chain in Central Mexico . ... June 2014 to eliminate payroll issues caused by employees ... to installing the U.are.U fingerprint readers, Montparnasse relied on ...
(Date:11/7/2014)... 2014 Leading Biometric companies aim to ... revolutionizing online transactions.  Companies in focus today are: NXT-ID, Inc. ... BABA ), Google Inc. (NASDAQ: GOOG ), ... EBAY ) and MasterCard Inc. (NYSE: MA) ... a biometric authentication company focused on the growing mobile commerce ...
(Date:11/5/2014)... biology in the UTSA College of Sciences, is ... to receive a two-year $300,00 National Science Foundation ... The funding supports President Obama,s BRAIN Initiative, a ... technology that will demystify complex brain processes. ... are broken into the interactions of multiple components, ...
Breaking Biology News(10 mins):Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6UTSA biology professor awarded $300,000 NSF grant for brain research 2UTSA biology professor awarded $300,000 NSF grant for brain research 3
... A new analysis has provided a comprehensive comparison of ... breast cancer are at high risk of recurrence beyond ... endocrine treatment. The promising new findings will likely ... whose cancer recurs more than five years after diagnosis, ...
... led by prominent breast cancer experts from Europe and ... prospects for targeted therapies, and brings opportunities of truly ... said at the 5th IMPAKT Breast Cancer Conference in ... ,translational, breast cancer research that is beginning to have ...
... healthy people have been bombarded by stories in the media ... vitamin D levels, and urging high doses of supplements to ... to diabetes. But new research from Johns Hopkins finds ... the top of the range suggested by the Institute of ...
Cached Biology News:Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer 2Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer 3Study opens new prospects for developing new targeted therapies for breast cancer 2Study opens new prospects for developing new targeted therapies for breast cancer 3Vitamin D: More may not be better 2
Mouse monoclonal [15-2] to Mannose Receptor (Biotin) ( Abpromise for all tested applications). entrezGeneID: 4360 SwissProtID: P22897...
Request Info...
Mouse monoclonal [DJR3] to DcR1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 8794 SwissProtID: O14798...
...
Biology Products: